China IPO Plans By More Than 20 Pharma Firms In May
This article was originally published in PharmAsia News
Executive Summary
More than 20 companies have unveiled plans for initial public offerings in May in China following a regulatory decision this year to resume such share sales after they were curbed last year to dampen primary market speculation.